In the past few years, the medical marijuana and hemp industry has seen explosive growth to become the fastest growing industry in the United States with revenue of $1.5 billion in 2013 to $2.7 billion in 2014 - an impressive 74% year over year increase. With many states adopting legislation legalizing marijuana use for medicinal and recreational purposes, as well as legislation that relates to industrial and recreational hemp use, the industry is witnessing a seismic shift in public opinion and regulatory policy; all of which has resulted in rapid expansion for the hemp and CBD industry.
Capitalizing on our mergers and acquisitions background through ADM Group, ADM Labs was created as a subsidiary of ADM Group to expand on our business in the cannabis market with a specific focus on hemp and CBD extraction. ADM Labs is making use of market data-driven analysis to finally capitalize on an industry expected to balloon to over $40 billion in the US and over $100 billion worldwide.
ADM Labs focuses on the extraction of CBD as well as the wholesale of industrial hemp. We sell to the manufacturing and wholesale segments of the industrial hemp supply chain; producing CBD oils and selling them directly to hemp derivative product makers and retailers as well as offering white label solutions for international brands. To this end, ADM Labs offers investors consistent growth at a level deserving of their loyalty, but with quantifiable returns through an unprecedented level of communication and leadership. Our clients and partners know that we deliver on this mission. Just as ADM Group has become an indispensable partner to the world’s most distinguished business owners, ADM Labs aims to capitalize on its position as one of the most distinguished leaders in the CBD industry. Join us on this momentous journey.